Charles Schwab Investment Management Inc. Cuts Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Charles Schwab Investment Management Inc. lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 29.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 429,689 shares of the biotechnology company’s stock after selling 180,321 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Axon Enterprise were worth $171,704,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Quent Capital LLC lifted its holdings in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares in the last quarter. Blue Trust Inc. boosted its position in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Planning Capital Management Corp grew its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares in the last quarter. Friedenthal Financial acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $51,000. Finally, Reston Wealth Management LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $60,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 0.9 %

NASDAQ:AXON opened at $636.95 on Friday. Axon Enterprise, Inc. has a 52 week low of $224.28 and a 52 week high of $641.20. The stock’s fifty day moving average is $463.58 and its two-hundred day moving average is $368.07. The stock has a market capitalization of $48.57 billion, a price-to-earnings ratio of 164.59, a price-to-earnings-growth ratio of 18.89 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 70,000 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $362.21, for a total value of $25,354,700.00. Following the completion of the transaction, the chief executive officer now owns 2,945,366 shares of the company’s stock, valued at $1,066,841,018.86. This trade represents a 2.32 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 330,256 shares of company stock valued at $131,338,820. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on AXON. Craig Hallum increased their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Northland Securities raised their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.